Research Reports

Key takeaways

Underwriter fully exercised the over-allotment option to purchase 3,000,000 units at $10.00 per unit on April 20, 2026.

Gross proceeds of $30,000,000 were generated from the over-allotment option exercise.

Total funds placed in the trust account increased to $230,000,000, including $12,650,000 in deferred underwriting fees.

Each Option Unit consists of one Class A ordinary share and one-sixth of one warrant exercisable at $11.50 per share.

750,000 Class B ordinary shares are no longer subject to forfeiture following the full exercise of the over-allotment option.

Full analysis

KPET Ultra Paceline Corporation consummated the issuance of 3,000,000 units on April 20, 2026, following the underwriter's full exercise of its over-allotment option on April 15, 2026. The Option Units were sold at $10.00 per unit, generating $30 million in gross proceeds. This transaction follows the Company's initial public offering of 20,000,000 units on April 1, 2026. As a result of the full exercise, 750,000 Class B founder shares are no longer subject to forfeiture. The aggregate amount held in the trust account totaled $230,000,000 as of April 20, 2026, which includes $12,650,000 of deferred underwriting discounts and commissions. The unaudited pro forma balance sheet reflects the adjustment of the over-allotment option liability and the accretion of ordinary shares subject to redemption.

KPET · KPET Ultra Paceline Corporation

Summary

Key takeaways

Full analysis